{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:19:08Z","timestamp":1791011948175,"version":"4.1.0"},"reference-count":51,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,1,23]],"date-time":"2008-01-23T00:00:00Z","timestamp":1201046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2008,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Serum tartrate\u2010resistant acid phosphatase (TRACP) 5b levels were assessed in predialysis patients with chronic kidney disease (CKD). The aim of the study was to establish the usefulness of a new assay for TRACP5b in assessing bone turnover in these patients.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Serum concentrations of two bone resorption markers, TRACP5b and N\u2010terminal cross\u2010linking telopeptide of type I collagen (NTX); two bone formation markers, bone specific alkaline phosphatase (bone ALP) and intact osteocalcin (OC[1\u201349]); and PTH were measured in 98 predialysis CKD patients.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Log serum TRACP5b and other bone markers were significantly negatively correlated with glomerular filtration rate (GFR) and positively correlated with log serum PTH, suggesting an increase in serum bone markers with development of secondary hyperparathyroidism. Multiple regression analysis including age, gender, BMI, the presence of diabetes, GFR and log serum PTH showed an association of log serum PTH with log serum TRACP5b and other bone markers. GFR was associated with log serum NTX and log OC[1\u201349], but not with log serum TRACP5b or log bone ALP. These data show that renal dysfunction does not influence serum TRACP5b and bone ALP, but has an influence on NTX and OC[1\u201349].<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> Serum TRACP5b may be a good marker for serum bone resorption in predialysis CKD patients, as it is not affected by renal dysfunction.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2008.03187.x","type":"journal-article","created":{"date-parts":[[2008,7,15]],"date-time":"2008-07-15T09:28:15Z","timestamp":1216114095000},"page":"189-196","source":"Crossref","is-referenced-by-count":113,"title":["Utility of serum tartrate\u2010resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction"],"prefix":"10.1111","volume":"69","author":[{"given":"Shinsuke","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kurajoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Shidara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Imanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Ishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,7,15]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"57","article-title":"Fractures and vertebral bone mineral density in patients with renal osteodystrophy","volume":"30","author":"Piraino B.","year":"1988","journal-title":"Clinical Nephrology"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2001.01139.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.051524"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-004-1712-4"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0753-3322(02)00344-X"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.8.1537"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2005.02.007"},{"key":"e_1_2_5_9_2","first-page":"81","article-title":"PICP as bone formation and NTx as bone resorption maker in patients with chronic renal failure","volume":"21","author":"Franke S.","year":"1998","journal-title":"European Journal of Medical Research"},{"key":"e_1_2_5_10_2","first-page":"78","article-title":"Investigations of bone turnover in renal osteopathy","volume":"25","author":"M\u00fcller A.","year":"1999","journal-title":"European Journal of Medicine Research"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.7.1337"},{"key":"e_1_2_5_12_2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1242\/jcs.113.3.377","article-title":"The cell biology of osteoclast function","volume":"113","author":"Vaananen H.K.","year":"2000","journal-title":"Journal of Cell Science"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00203-8"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-001-2122-7"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1998.13.4.683"},{"key":"e_1_2_5_16_2","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/clinchem\/41.10.1495","article-title":"Generation and characterization of monoclonal antibodies to human type\u20105 tartrate\u2010resistant acid phosphatase: development of a specific immunoassay of the isoenzyme in serum","volume":"41","author":"Chamberlain P.","year":"1995","journal-title":"Clinical Chemistry"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(02)00431-X"},{"key":"e_1_2_5_18_2","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1093\/clinchem\/45.12.2150","article-title":"Clinical significance of immunoassays for type\u20105 tartrate\u2010resistant acid phosphatase","volume":"45","author":"Nakasato Y.R.","year":"1999","journal-title":"Clinical Chemistry"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2003.04.002"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(99)90227-5"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80313-1"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0247-y"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1688"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2006.08.021"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(98)00126-4"},{"key":"e_1_2_5_26_2","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/clinchem\/41.11.1560","article-title":"Monoclonal antibody assay for measuring bone\u2010specific alkaline phosphatase activity in serum","volume":"41","author":"Gomez B.","year":"1995","journal-title":"Clinical Chemistry"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.11.4157"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980050180"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(99)00251-X"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2001.16.4.605"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2003.026831"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg144"},{"key":"e_1_2_5_33_2","first-page":"295","article-title":"Elecsys parathyroid hormone (PTH) not detecting the large PTH fragment hPTH (7\u201384)?","volume":"46","author":"Roth H.J.","year":"2000","journal-title":"Clinical Laboratory"},{"key":"e_1_2_5_34_2","first-page":"449","article-title":"Influence of 25\u2010hydroxyvitamin D concentration on the reference range of intact PTH","volume":"12","author":"Inomata K.","year":"2004","journal-title":"Osteoporosis Japan"},{"key":"e_1_2_5_35_2","first-page":"243","article-title":"Development and clinical application of Whole PTH (PTH1\u201384) kit","volume":"48","author":"Yamasita H.","year":"2002","journal-title":"Japanese Journal of Medicine and Pharmaceutical Science"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-004-0547-6"},{"key":"e_1_2_5_37_2","first-page":"171","article-title":"Serum cross\u2010linked N\u2010telopeptide of type I collagen (NTX) and serum amino\u2010terminal propeptide of type I procollagen (PINP) in residents of a rural community in Japan. Reference value classified by age and sex","volume":"10","author":"Yoshimura N.","year":"2002","journal-title":"Osteoporosis Japan"},{"key":"e_1_2_5_38_2","first-page":"981","article-title":"Reference database of biochemical markers of bone turnover for the Japanese female population","volume":"15","author":"Iki M.","year":"2004","journal-title":"Japanese Population-based Osteoporosis (JPOS) Study Osteoporosis International"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.35692"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.27436"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-004-1715-1"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001600"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-1642"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-004-1819-7"},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-004-0028-x"},{"key":"e_1_2_5_46_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-1020"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2003.04.002"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.0301244"},{"key":"e_1_2_5_49_2","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/clinchem\/47.3.597","article-title":"Serum tartrate\u2010resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption","volume":"47","author":"Halleen J.M.","year":"2001","journal-title":"Clinical Chemistry"},{"key":"e_1_2_5_50_2","doi-asserted-by":"publisher","DOI":"10.1080\/17453670710013717"},{"key":"e_1_2_5_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-006-0286-8"},{"key":"e_1_2_5_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00203-8"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2008.03187.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2008.03187.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T20:20:07Z","timestamp":1697228407000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2008.03187.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,15]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["10.1111\/j.1365-2265.2008.03187.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03187.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,15]]}}}